Opposition criticizes health insurer merger, warns of monopoly and weakened patient rights

Slovakia's opposition parties are voicing strong criticism against the proposed merger of two major health insurance providers, Dôvera and Union. They argue that combining these entities would lead to an unacceptable level of market concentration, effectively creating a monopoly.

According to critics, such a merger poses a significant threat to patients. They contend that reduced competition would inevitably weaken patient protections and potentially lead to diminished service quality or increased costs. The Progressive Slovakia (PS) party has taken a leading role in opposing the deal, urging regulatory bodies to intervene.

The PS party specifically called upon the Antimonopoly Office of the Slovak Republic to act decisively. They are demanding that the office investigate the potential consequences of the merger and prevent the creation of a dominant market player that could disadvantage the public. The opposition's stance highlights concerns about market fairness and patient welfare within Slovakia's healthcare system.